Watts Ryan J.

President And CEO

1 company

Excellent

Trades Analyzed

12M Win Rate

87.1%

Avg 3M Return

+11.2%

Avg 12M Return

+29.5%

Watts Ryan J. is a President And CEO at Denali Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $5.9M based on current market prices.

Holdings by Company

DNLIJan 6, 2026

Current Shares296.8K

Value$5.85M

Net Activity-1,421,181

Bought: 0Sold: 1.42M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 6, 2026	DNLI Denali Therapeutics Inc.	President And CEO	Sell	35,198	$16.50	$580,767.00	-10.6%	+12.6%	-
Jul 9, 2025	DNLI Denali Therapeutics Inc.	President And CEO	Sale+OE	495,282	$15.00	$7,429,230.00	-66.2%	-0.7%	-
Jan 7, 2025	DNLI Denali Therapeutics Inc.	President And CEO	Sell	36,916	$20.34	$750,955.02	-6.7%	-45.2%	-20.0%
Oct 18, 2024	DNLI Denali Therapeutics Inc.	President And CEO	Sale+OE	40,000	$27.69	$1,107,600.00	-14.5%	-21.5%	-39.6%
Aug 20, 2024	DNLI Denali Therapeutics Inc.	President And CEO	Sell	2,260	$23.79	$53,765.40	-0.9%	+2.2%	-38.6%
Feb 13, 2024	DNLI Denali Therapeutics Inc.	President And CEO	Sell	9,589	$17.29	$165,793.81	-3.9%	+13.1%	+22.0%
Jan 9, 2024	DNLI Denali Therapeutics Inc.	President And CEO	Sell	7,818	$19.78	$154,640.04	-0.3%	-3.5%	+7.6%
Jan 5, 2024	DNLI Denali Therapeutics Inc.	President And CEO	Sell	17,483	$19.43	$339,694.69	-0.8%	-1.8%	+9.9%
Aug 21, 2023	DNLI Denali Therapeutics Inc.	President And CEO	Sell	2,309	$22.59	$52,160.31	-0.1%	-17.5%	+1.6%
Aug 10, 2023	DNLI Denali Therapeutics Inc.	President And CEO	Sale+OE	2,526	$25.03	$63,225.78	-0.1%	-16.7%	-7.6%